Naamit Sher

Keine laufenden Positionen mehr

71 Jahre

Health Technology

Consumer Services

Profil

Naamit Sher worked as the VP of Drug Development & Regulatory Affairs at Vascular Biogenics Ltd. She was also the Director of Quality Control & Quality Assurance at Interpharm Laboratories Ltd. and the Head of QC Laboratories at Teva Pharmaceutical Industries Ltd. Additionally, she held the title of Principal at Teva North America.
Dr. Sher received her undergraduate, graduate, and doctorate degrees from The Hebrew University of Jerusalem.

Ehemalige bekannte Positionen von Naamit Sher

Unternehmen	Position	Ende
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	Corporate Officer/Principal	01.01.2006
Teva North America	Corporate Officer/Principal	-
Interpharm Laboratories Ltd. Interpharm Laboratories Ltd. BiotechnologyHealth Technology Develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases	Corporate Officer/Principal	-
NOTABLE LABS, LTD.	General Counsel	-

Sehen Sie sich die Erfahrung von Naamit Sher im Detail an

Ausbildung von Naamit Sher

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Naamit Sher im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	5
Teva Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients	Health Technology
The Hebrew University of Jerusalem The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Teva North America
Interpharm Laboratories Ltd. Interpharm Laboratories Ltd. BiotechnologyHealth Technology Develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases	Health Technology
Vascular Biogenics Ltd. Vascular Biogenics Ltd. BiotechnologyHealth Technology Develops novel treatments for atherosclerosis and cancer	Health Technology